Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy.

J Allergy Clin Immunol

Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London, United Kingdom; Asthma UK Centre in Allergic Mechanisms of Asthma, London, Imperial College London, London, United Kingdom. Electronic address:

Published: February 2021

Background: Allergen-specific immunotherapy is a disease-modifying treatment that induces long-term T-cell tolerance.

Objective: We sought to evaluate the role of circulating CXCR5PD-1 T follicular helper (cT) and T follicular regulatory (T) cells following grass pollen subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) and the accompanying changes in their chromatin landscape.

Methods: Phenotype and function of cT cells were initially evaluated in the grass pollen-allergic (GPA) group (n = 28) and nonatopic healthy controls (NAC, n = 13) by mathematical algorithms developed to manage high-dimensional data and cell culture, respectively. cT and T cells were further enumerated in NAC (n = 12), GPA (n = 14), SCIT- (n = 10), and SLIT- (n = 8) treated groups. Chromatin accessibility in cT and T cells was assessed by assay for transposase-accessible chromatin sequencing (ATAC-seq) to investigate epigenetic mechanisms underlying the differences between NAC, GPA, SCIT, and SLIT groups.

Results: cT cells were shown to be distinct from T2- and T2A-cell subsets, capable of secreting IL-4 and IL-21. Both cytokines synergistically promoted B-cell class switching to IgE and plasma cell differentiation. Grass pollen allergen induced cT-cell proliferation in the GPA group but not in the NAC group (P < .05). cT cells were higher in the GPA group compared with the NAC group and were lower in the SCIT and SLIT groups (P < .01). Time-dependent induction of IL-4, IL-21, and IL-6 was observed in nasal mucosa following intranasal allergen challenge in the GPA group but not in SCIT and SLIT groups. T and IL-10 cT cells were induced in SCIT and SLIT groups (all, P < .01). ATAC-seq analyses revealed differentially accessible chromatin regions in all groups.

Conclusions: For the first time, we showed dysregulation of cT cells in the GPA group compared to NAC, SCIT, and SLIT groups and induction of T and IL-10 cT cells following SCIT and SLIT. Changes in the chromatin landscape were observed following allergen-specific immunotherapy in cT and T cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2020.10.035DOI Listing

Publication Analysis

Top Keywords

scit slit
24
gpa group
20
slit groups
16
grass pollen
12
cells
11
chromatin landscape
8
follicular helper
8
regulatory cells
8
cells grass
8
pollen subcutaneous
8

Similar Publications

[Clinical efficacy of sublingual immunotherapy for allergic rhinitis].

Nihon Yakurigaku Zasshi

January 2025

Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University.

The prevalence of allergic rhinitis (AR) reached 49.2% in 2019. In particular, the prevalence of Japanese cedar (JC) pollinosis is 38.

View Article and Find Full Text PDF

Application of Nanoparticles for Immunotherapy of Allergic Rhinitis.

Int J Nanomedicine

November 2024

Laboratory Medicine Center, Allergy Center, Department of Transfusion Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, People's Republic of China.

Article Synopsis
  • Allergen Immunotherapy (AIT) is currently the only treatment that targets the root cause of allergic rhinitis (AR), with established methods like subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) showing positive results but also side effects.
  • Innovative approaches using nanoparticles (NPs), which are tiny particles (1-100 nm), are being explored as safer and more effective delivery systems for AIT, potentially enhancing immune modulation and drug concentration.
  • The review discusses various types of nanoparticle delivery systems, such as chitosan, exosomes, metal, and viral nanoparticles, while highlighting their advantages and limitations, indicating that more research is needed to confirm their effectiveness in treating AR.
View Article and Find Full Text PDF

Objective: To evaluate the efficacy of subcutaneous specific immunotherapy (SCIT) for allergic rhinitis (AR) combined with asthma.

Methods: A retrospective analysis of clinical data from 93 patients with AR combined with asthma admitted to our hospital from January 2022 to January 2023 was conducted. Based on the treatment interventions received, the patients were divided into a control group (n=46, receiving sublingual specific immunotherapy [SLIT]) and an observation group (n=47, receiving SCIT).

View Article and Find Full Text PDF

: Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are commonly used for allergic rhinitis (AR), yet limited research has directly compared their effects on quality of life (QoL). We aimed to assess QoL differences between SLIT and SCIT recipients. As both forms of immunotherapy have reported benefits, we hypothesize that patients undergoing SLIT and SCIT will have comparable QoL improvements.

View Article and Find Full Text PDF
Article Synopsis
  • Food allergies have risen significantly in young children, impacting quality of life and healthcare costs, leading to a focus on Food Allergy Allergen Immunotherapy (FA-AIT) as a treatment option.
  • FA-AIT methods, including SCIT, EPIT, OIT, and SLIT, involve gradual exposure to allergens to build tolerance, but they can also cause adverse reactions.
  • Recent research highlights the potential of gut microbiota and specific probiotics as adjuvants to improve the safety and effectiveness of AIT, emphasizing the need for more clinical studies to validate these approaches.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!